Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Kura Oncology, Inc. shares are trading higher Tuesday after the company reported preliminary clinical data from the first 20 patients its Komet-007 Phase 1 dose-escalation trial. Kura reported that all newly diagnosed patients treated with ziftomenib and 7+3 achieved a complete remission (CR) with full count recovery, for a CR rate of 100% (5/5), including four patients with NPM1-m acute myeloid leukemia (AML) and one patient with KMT2A-r AML.
Janet Mills AWOL After Deadly Storm Grinds Maine to a Halt, Hundreds of Thousands Still Without Power As Temps Plunge themainewire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themainewire.com Daily Mail and Mail on Sunday newspapers.
Report Reveals Over 97,000 University Staff Underpaid Nearly $159 Million theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.